Prometheus Biosciences, Inc.

Connor, Clark & Lunn Investment Management Ltd.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/10/2023

Shares

3,827

Value ($000)

411

Weight

0.0%

2022 Q4 - 2023 Q1 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/10/2023	411	0.0%	3,827	3/31/2023
2022 Q4	2/10/2023	1,405	0.0%	12,774	12/31/2022